* The Food and Drug Administration is requiring the manufacturer of fenofibric acid (Trilipix), also called fenofibrate, to complete a clinical trial to determine the drug's efficacy in reducing cardiovascular events in patients with type 2 diabetes who are already taking a statin.Diane S. ...
109TriLipix - joining the list 113Development overview 113Product positioning 114Drug forecast to 2017 115The rest of the pipeline - the reasons behind the lack of blockbuster 116Livalo - not fitting into the overcrowded market 116Dalcetrapib and anacetrapib - C...